Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Berenberg raises target price on FRP Advisory

(Sharecast News) - Analysts at Berenberg took a fresh look at the British insolvency services market on Thursday as it dissected the impact of the Labour Party's recent UK election victory on the sector. Berenberg said the election, which gave the Labor Party a 167-seat majority and "a very public focus" on economic growth, may lead one to question if the UK was entering the early stages of a period of sustained growth, particularly given the recent acceleration in GDP in Q124.

"While this could prove to be true, a read-across expectation to a softening in UK insolvency activity is not so direct. Typically, changes in insolvency appointments materially lag prevailing economic conditions, while the UK economy (still in recovery mode) continues to slowly repay the large amount of government stimulus built up over the Covid-19 pandemic. Concurrently, individual businesses are facing, or are already locked into, materially higher funding costs," said Berenberg.

"Our analysis suggests that the UK is still at the early to mid-stages of a backlog of insolvency cases still to be realised, with many businesses still pursuing all remaining financing options available before declaring insolvency. Given this, we believe the listed insolvency practitioners still provide investors with exposure to industry-driven growth and returns."

The German bank stated FRP Advisory, the largest UK appointment taker for administrations, offers exposure to what it thinks will play out as accelerated structural growth. Berenberg raised its target price on the 'buy' rated stock from 200.0p to 220.0p.

As far as Begbies Traynor was concerned, the UK's largest appointment taker for liquidations has demonstrated "a strong post-pandemic rebound", now stabilising at elevated levels over the last two-and-a-half years. However, Begbies shares have "materially de-rated" since the turn of the year, currently standing at historically low multiples despite a positive recent trading outlook, indicating growth across all service lines.

"With solid forecast organic EPS growth, alongside M&A optionality required to meet a targeted £200.0m of revenue, we view current pricing as anomalous. We update our price target to 150.0p (from 170.0p) today," said Berenberg.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

Smith & Nephew appoints Ajay Dhankhar as chief corporate development & strategy officer
(Sharecast News) - Medical technology company Smith & Nephew said on Monday that it has appointed Ajay Dhankhar as chief corporate development & strategy officer with immediate effect.
Oxford Biomedica acquires last 10pc stake in US subsidiary
(Sharecast News) - Oxford Biomedica said on Monday it has acquired the remaining 10% stake in its US subsidiary, OXB US, from Q32 Bio, bringing its ownership of the business to 100% as previously planned.
PPHE acquiring prime London site for hotel development
(Sharecast News) - PPHE Hotel Group has announced the acquisition of a prime development site near the City of London, where it plans to build its first Radisson RED select service hotel in the capital.
Norcros to end tile production in South Africa
(Sharecast News) - Norcros announced on Monday that it will shut down manufacturing at Johnson Tiles South Africa at the end of June, following the conclusion of a strategic review.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.